BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 37822213)

  • 41. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.
    Han K; Kim JH
    World J Gastroenterol; 2015 Sep; 21(36):10327-35. PubMed ID: 26420959
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of repeated proton beam therapy for patients with hepatocellular carcinoma.
    Oshiro Y; Mizumoto M; Okumura T; Fukuda K; Fukumitsu N; Abei M; Ishikawa H; Takizawa D; Sakurai H
    Radiother Oncol; 2017 May; 123(2):240-245. PubMed ID: 28366501
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Conformal radiotherapy for hepatocellular carcinoma.
    Tse RV; Guha C; Dawson LA
    Crit Rev Oncol Hematol; 2008 Aug; 67(2):113-23. PubMed ID: 18308583
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma.
    Cheng JC; Chuang VP; Cheng SH; Huang AT; Lin YM; Cheng TI; Yang PS; You DL; Jian JJ; Tsai SY; Sung JL; Horng CF
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):435-42. PubMed ID: 10802371
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proton beam therapy versus stereotactic body radiotherapy for hepatocellular carcinoma: practice patterns, outcomes, and the effect of biologically effective dose escalation.
    Hasan S; Abel S; Verma V; Webster P; Arscott WT; Wegner RE; Kirichenko A; Simone CB
    J Gastrointest Oncol; 2019 Oct; 10(5):999-1009. PubMed ID: 31602338
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radiofrequency Ablation Combined With Transarterial Chemoembolization for Specially Located Small Hepatocellular Carcinoma.
    Yuan W; Yang MJ; Xu J; Yan ZP; Liu R; Qu XD; Wang JH; Qian S
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818788529. PubMed ID: 30045673
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proton beam therapy for tumors of the upper abdomen.
    Raldow A; Lamb J; Hong T
    Br J Radiol; 2020 Mar; 93(1107):20190226. PubMed ID: 31430202
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and safety of external-beam radiation therapy for hepatocellular carcinoma: An overview of current evidence according to the different target population.
    Han B; Li C; Meng H; Gomes Romeiro F; Mancuso A; Zhou Z; Levi Sandri GB; Xu Y; Han T; Han L; Shao L; Qi X
    Biosci Trends; 2019 Mar; 13(1):10-22. PubMed ID: 30799321
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and Safety of Combined Radiofrequency Ablation with Transarterial Chemoembolization in Patients with Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma Ineligible for Curative Treatment.
    Kim AR; Park E; Kwon SY; Park SJ; Kim YJ; Yoo BC; Choe WH; Kim JH; Hwang JH; Park SW; Kim YJ; Park HS; Yu MH; Jeon HJ
    Korean J Gastroenterol; 2019 Mar; 73(3):167-176. PubMed ID: 31013560
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combination of Lenvatinib and Proton Beam Therapy in the Management of Patients With Advanced Hepatocellular Carcinoma.
    Cheng JY; Huang BS; Chen YY; Wang CC; Chen YH
    Anticancer Res; 2023 Mar; 43(3):1361-1371. PubMed ID: 36854503
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proton beam stereotactic body radiotherapy and hypofractionated therapy with pencil beam scanning is safe and effective for advanced hepatocellular carcinoma and intrahepatic cholangiocarcinoma: A single center experience.
    Yang AH; Urrunaga NH; Siddiqui O; Wu A; Schliep M; Mossahebi S; Shetty K; Regine WF; Molitoris JK; Lominadze Z
    J Radiosurg SBRT; 2023; 9(1):43-52. PubMed ID: 38029012
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: the PROMETHEUS-01 trial.
    Combs SE; Habermehl D; Ganten T; Schmidt J; Edler L; Burkholder I; Jäkel O; Haberer T; Debus J
    BMC Cancer; 2011 Feb; 11():67. PubMed ID: 21314962
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combined Therapy with Transarterial Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma: Does the Degree of Ethiodized Oil Accumulation within the Tumor Affect the Therapeutic Efficacy?
    Lee JE; Kim JW; Kim HO; Lee BC; Hur YH; Cho SB; Cho YS; Seon HJ; Kim D
    J Vasc Interv Radiol; 2019 Mar; 30(3):370-379.e4. PubMed ID: 30819479
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparison of carbon ion radiotherapy and transarterial chemoembolization treatment outcomes for single hepatocellular carcinoma: a propensity score matching study.
    Shiba S; Shibuya K; Katoh H; Kaminuma T; Miyazaki M; Kakizaki S; Shirabe K; Ohno T; Nakano T
    Radiat Oncol; 2019 Aug; 14(1):137. PubMed ID: 31375120
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dose escalation in radiotherapy for incomplete transarterial chemoembolization of hepatocellular carcinoma.
    Byun HK; Kim HJ; Im YR; Kim DY; Han KH; Seong J
    Strahlenther Onkol; 2020 Feb; 196(2):132-141. PubMed ID: 31286149
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypofractionated proton beam radiotherapy in patients with unresectable liver tumors: multi-institutional prospective results from the Proton Collaborative Group.
    Parzen JS; Hartsell W; Chang J; Apisarnthanarax S; Molitoris J; Durci M; Tsai H; Urbanic J; Ashman J; Vargas C; Stevens C; Kabolizadeh P
    Radiat Oncol; 2020 Nov; 15(1):255. PubMed ID: 33148296
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea.
    Choi JY
    Oncology; 2011; 81 Suppl 1():141-7. PubMed ID: 22212948
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A validated proton beam therapy patch-field protocol for effective treatment of large hepatocellular carcinoma.
    Nakamura M; Fukumitsu N; Kamizawa S; Numajiri H; Nemoto Murofushi K; Ohnishi K; Aihara T; Ishikawa H; Okumura T; Tsuboi K; Sakurai H
    J Radiat Res; 2018 Sep; 59(5):632-638. PubMed ID: 30085200
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A preliminary study of hepatocellular carcinoma post proton beam therapy using MRI as an early prediction of treatment effectiveness.
    Lin SY; Chen CM; Huang BS; Lai YC; Pan KT; Lin SM; Chu SY; Tseng JH
    PLoS One; 2021; 16(3):e0249003. PubMed ID: 33755701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.